Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer

NCT01613677 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Treatment for Metastatic or Locally Advanced Cervical Cancer

Interventions

DRUG: BKM120

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]